Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


E-Letter responses to:

reports:
Andreas Pichlmair, Oliver Schulz, Choon Ping Tan, Tanja I. Näslund, Peter Liljeström, Friedemann Weber, and Caetano Reis e Sousa
RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates
Science 2006; 314: 997-1001 [Abstract] [Full text] [PDF]
*E-Letters: Submit a response to this article

Published E-Letter responses:

[Read E-Letter] Low Level Expression of RIG-1 in Human Lung Epithelium Allows Influenza Virus to Replicate
Syed H. I. Abidi   (4 April 2007)

Low Level Expression of RIG-1 in Human Lung Epithelium Allows Influenza Virus to Replicate 4 April 2007
  Top
Syed H. I. Abidi,
Graduate Student
University of Oxford, Department of Medicine, WIMM MRC Human Immunology Unit, UK

Respond to this E-Letter:
Re: Low Level Expression of RIG-1 in Human Lung Epithelium Allows Influenza Virus to Replicate

The ability of viral infected cells to detect and initiate an antiviral response before the activation of immune responses is central to the control of intracellular infections. Recently, Hornung (1) and Pichlmair (3) showed that RIG-I can scan viral ssRNA to produce type I interferon that may block viral replication in infected cells. However, both studies used influenza ssRNA to transfect human HEK293 or mice NIH 3T3 cells to trigger RIG-I mediated antiviral response. Although these cell types clearly have the ability to detect and mount antiviral responses, they are not the preferred host target cells for virus attachment and infection. In vivo, influenza viruses primarily infect ciliated airway epithelial cells lining the respiratory tracts of mice and humans (4). Considering that an early antiviral response mounted by epithelial tissues would inhibit the spread of infection well before the involvement of immune cells, it is important to consider the expression pattern of RIG-I in lung tissues.

Using the serial analysis of gene expression (SAGE) method, which generates short, transcript-specific tags that can be sequenced at high throughput (5), the expression pattern of RIG-I gene was checked in a total of ten leukocytes and lung tissues. Surprisingly, a low level expression of RIG-I was detected in SAGE libraries prepared from the lung tissues. In contrast, SAGE libraries prepared from leukocyte cells showed moderate to high expression that coincides with their ability to detect and initiate antiviral responses. The detection of moderate and high numbers of RIG-I transcript in libraries of comparable sizes prepared from leukocyte cells confirmed that the low level expression of RIG-I tag was not the result of inadequate sampling or tag misidentification (6).

This result may explain why influenza viruses prefer to replicate in lung epithelial tissues. The evolutionary pressure may have shaped the virus to successfully co-opt host cell processes for replicating in epithelial lung tissues because of the low expression of RIG-I gene. In order to design therapeutic regimes, for augmenting RIG-I mediated antiviral responses, focus should be directed toward the selective induction of RIG-I expression in airway epithelial tissues.

References:

1. V. Hornunget al., Science 314, 994 (2006).

2. A. Pichlmair et al., Science 314, 997 (2006).

3. A. Ibricevic et al., J. Virol. 80, 7469 (2006).

4. V. E. Velculescu et al., Science 270, 484 (1995).

5. J. Stollberg et al., Genome Res. 10, 1241 (2000).

6. E. J. Evans et al., Immunity 19, 213 (2003).


To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)